A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-6901
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions ; volume:17 ; number:3 ; day:29 ; month:7 ; year:2017 ; pages:427-434 ; date:9.2017
Drugs in R & D ; 17, Heft 3 (29.7.2017), 427-434, 9.2017

Keyword
Krebs
Onkologie

Creator
Muggeri, Alejandro
Contributor
Vago, Miguel
Pérez, Sebastián
Rubio, Marcelo
González, Cecilia
Magariños, Cristian
Rosenberg, Mónica
Costa, Fernando
Perez-Lloret, Santiago
SpringerLink (Online service)

DOI
10.1007/s40268-017-0199-3
URN
urn:nbn:de:1111-201711295570
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Muggeri, Alejandro
  • Vago, Miguel
  • Pérez, Sebastián
  • Rubio, Marcelo
  • González, Cecilia
  • Magariños, Cristian
  • Rosenberg, Mónica
  • Costa, Fernando
  • Perez-Lloret, Santiago
  • SpringerLink (Online service)

Other Objects (12)